Guided by the aim of drastically shortening the time-lag from basic research discoveries to the clinic and socio-economic valorization and pushing translation of findings into real life through public-private partnerships, CARe promotes a unique range of educational tracks from master’s to PhD involving all the academic, industrial, socio-economic actors.
This EUR: « Post-graduate training program », based on the unique « Langlade Campus Biosanté», has a major structuring effect and boost international attractiveness by fostering ambitious and intimately synergistic research, development and innovative educational actions.
The rationale of such an EUR is based on common concepts developed on both ageing and cancer from a very detailed mechanistic up to an « in-use » therapeutic view. They are proposed all along the 2 years master’s PhD-track through an original education program, widely open to international partners and tightly linked to our entire industrial and academic network, including technological platforms, clinical services and socio-economic actors. In this view, CARe proposes a complete transversal program allowing to professionals and leaders of tomorrow to be skilled in fields that are key for the medicine and biomedical sciences of the future. It means that biomedical sciences will be complemented for our students with innovative interdisciplinary courses, including engineering, informatics, and mathematics. From year 1, students are in permanent immersion in academic or industrial research laboratories to facilitate training through research.
The strong interplay between the universities involved in CARe favors both incoming and outcoming student fluxes and the establishment of future competitive networks. Thus, dedicated mobility scholarships are offered to outstanding foreign and domestic students in order to improve communication skills and develop new expertises. Our ambition for the CARe PhD track is to dramatically modify the “classical” vertical way of teaching by focusing on the following objectives.
We have been creating an international network of strategic and outstanding partners for the next 10 years: Center on ageing, Mayo clinic (USA); Molecular Biology Center (Madrid); Geriatric center, Milan (Italy); Barcelona Supercomputing Center (Barcelona)… Furthermore, CARe is supported by key international companies (Roche, Nestlé, Pierre Fabre, Thales, Alphamos, Ambiotis,…), major research institutes (Univ. of Toulouse, Inserm, CNRS, INSA, Genotoul, EFS), foundations (Toulouse Cancer Santé, La Ligue contre le Cancer 31) and institutional partners (Région Occitanie, Toulouse metropole).
